Tatiana Gladysheva

Papers

Total Citations

H-Index

About

Tatiana Gladysheva is a leading figure in laboratory automation and high-throughput biochemical analysis, with a focus on transforming drug discovery workflows. Her primary research areas include robotic process automation, multiplex assay development, and the optimization of the design-make-test-analyze (DMTA) cycle in pharmaceutical and biotechnology settings. Gladysheva’s major contribution is the design and validation of a modular robotic platform that automates multiplex biochemical assays, enabling simultaneous collection of multiparameter data in a single run. This innovation directly addresses industry challenges by significantly reducing cycle times and enhancing productivity—a critical advancement for accelerating compound screening and development. Her most-cited work, "Automation of multiplex biochemical assays to enhance productivity and reduce cycle time using a modular robotic platform" (2024), has already garnered 2 citations, reflecting its early impact on streamlining DMTA processes. Gladysheva’s achievements underscore her role in bridging automation engineering and bioanalytical science, offering scalable solutions that improve efficiency and data quality. Her research is particularly notable for its practical application in reducing bottlenecks in preclinical testing, making her a key contributor to the evolution of modern, automated laboratories.